Content matching 'Investigational New Drug'
Regional diffusion gradients of molecular factors provide developmental cues in neural tissue organoids
The Netherlands-based cell therapy company Kiadis Pharma BV is planning an initial public offering (IPO) of its shares on the Euronext stock exchanges in Amsterdam and Brussels to finance the clinical development of a cell therapy that helps reconstitute the immune system after a bone marrow transplant.
Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle
An eye on organoids: organoids and their use in retinal degeneration